Skip to main content
Heliyon logoLink to Heliyon
. 2019 Aug 3;5(8):e02174. doi: 10.1016/j.heliyon.2019.e02174

Efficient synthesis and antioxidant activity of novel N-propargyl tetrahydroquinoline derivatives through the cationic Povarov reaction

Yeray A Rodriguez Núñez a, Maximiliano Norambuena a, Arnold R Romero Bohorquez b, Alejandro Morales-Bayuelo c, Margarita Gutíerrez a,
PMCID: PMC6690562  PMID: 31417970

Abstract

New N-propargyl tetrahydroquinolines 6a-g have been synthesized efficiently through the cationic Povarov reaction (a domino Mannich/Friedel-Crafts reaction), catalyzed by Indium (III) chloride (InCl3), from the corresponding N-propargylanilines preformed, formaldehyde and N-vinylformamide, with good to moderate yields. All tetrahydroquinoline derivatives obtained were evaluated in vitro as free radical scavengers. Results showed that compound 6c presents a potent antioxidant effect compared with ascorbic acid, used as a reference compound. ADME predictions also revealed favorable pharmacokinetic parameters for the synthesized compounds, which warrant their suitability as potentials antioxidant. Additionally, a theoretical study using Molecular Quantum Similarity and reactivity indices were developed to discriminate different reactive sites in the new molecules in which the oxidative process occurs.

Keywords: Organic chemistry, Theoretical chemistry, Pharmaceutical chemistry, Tetrahydroquinolines, Propragylamines, Antioxidant activity, Free radical, Molecular quantum similarity measure

1. Introduction

In the research of biologically active molecules, free radicals have been linked to several degenerative diseases including neurodegenerative and cardiovascular disorder, atherosclerosis and cancer (Aruoma, 1998). Although the discovery of antioxidant compounds has been an area widely studied (Kouznetsov et al., 2011; Bulut et al., 2018; Martelli and Giacomini, 2018) it is necessary to continue in the search of new natural or synthetic compounds that can act as free radical scavengers and help in the treatment or control of diseases related to oxidative stress.

Heterocyclic compounds, especially nitrogen heterocycles, are a very important class of compounds with application in the pharmaceutical industries, which comprise about 60% of all pharmacological substances. The tetrahydroquinoline (THQ) ring system, in particular, is a common structural motif found in numerous biologically active natural products showing broad biological activities (Nammalwar and Bunce, 2014). Because of the significance of these scaffolds in drug discovery and medicinal chemistry, the development of new methodologies for the synthesis of THQs derivatives continues to be an active field of investigation, as is evidenced by the appearance of over 400 research articles in this area during the last years (Sridharan et al., 2011; Katritzky et al., 1996).

In the last decades, a great number of synthetic methods for access to THQs derivatives have been reported (Sridharan et al., 2011). In many cases, these methodologies involve an intramolecular Friedel-Crafts reaction of N-substituted anilines with a suitable functional group bound to the nitrogen atom (Abonia et al., 2013). In this sense, the use of multicomponent Povarov reaction, catalyzed by Lewis or Brønsted acids between N-arylimines (obtained from anilines and aryl (alkyl)aldehydes) and electron-rich alkenes, is maybe the most powerful tool that provides quick and efficiently THQ scaffold with great structural diversity. Recently, we have been successfully exploring the cationic version of the Povarov reaction (a domino Mannich/Friedel-Crafts reaction). This method resulted highly efficient to access different N-derivatives of THQs (Romero Bohórquez et al., 2016; Acelas et al., 2017), including the synthesis of new N-allyl/propargyl 1,2,3,4-THQs, promissory dual inhibitors against AChE and BChE enzymes (Rodriguez et al., 2016).

Diverse amine derivatives with the propargyl fragment in its structure are versatile compounds with demonstrated pharmacological and pharmaceutical applications such as antioxidant agents (Dragoni et al., 2006) and as inhibitors of some monoamine oxidases MAO-B. Selegiline, Rasagiline, Pargyline, and Ladostigil drugs are widely used as enzymatic inhibitors in treatments of neurodegenerative diseases (Fig. 1) (Baranyi et al., 2016; Bolea et al., 2013; Mao et al., 2015). Taking into account all the above, in the present study, we report the synthesis, spectroscopic characterization and antioxidant activity of a new series of N-propargyl-THQs obtained via mild and expeditious InCl3 catalyzed-cationic Povarov reaction. Results indicated that some THQs derivatives evaluated showed good activity as potential free radical scavengers. In addition, theoretical studies of Molecular Quantum Similarity Measure allowed explaining the biological activity reported. Local reactivity descriptors like the local softness and electrophilicity indices were obtained with the help of Fukui function calculation.

Fig. 1.

Fig. 1

Propargylamines inhibitors of monoamine oxidases MAO-A and MAO-B.

2. Results and discussion

The preparation of new N-propargyl THQs 6a-g via domino Mannich addition/Friedel-Crafts intramolecular alkylation reactions catalyzed by InCl3, was effective under mild condition reactions using N-propargylamines with formaline (37% in methanol) and N-vinylformamide as an electron-rich alkene. Acetonitrile (CH3CN) was used as solvent based on previous reports (Romero Bohórquez et al., 2016; Abonia et al., 2013). Synthetic route and structures of final compounds are shown in Scheme 1. According to the results, although fluctuations in the reaction yield were shown, in general, the reaction showed to be powerful synthetic strategy to obtain the corresponding 1,2,3,4-THQ compounds with high structural diversification (Table 1).

Scheme 1.

Scheme 1

Synthesis of N-propargyl THQs 6a-g from N-propargylamines via domino Mannich/Friedel-Crafts alkylation reactions.

Table 1.

Physicochemical parameters obtained for the new THQ compounds.

Compound R MW (g/mol) Time (h) Yield (%) m.p. (°C)a
3a H 131.17 3 51% Oil
3b CH3 145.20 3 49% Oil
3c OCH3 161.20 3 48% Oil
3d CH2CH3 159.23 3 45% Oil
3e Br 210.07 3 51% Oil
3f Cl 165.62 3 44% Oil
3g F 149.16 3 58% Oil
6a H 214.26 4 51% 118–120
6b CH3 228.29 4 95% 134–136
6c OCH3 244.29 4 66% 110–112
6d CH2CH3 242.32 4 31% 116–118
6e Br 293.16 4 52% 164–166
6f Cl 248.71 4 23% 158–160
6g F 232.25 4 71% 144–146
a

Uncorrected.

All new N-propargyl THQ derivatives 6a-g were obtained as stable solids and were characterized by IR, 1H-NMR, 13C-NMR, and MS. In the IR spectra, C=O vibration bands (1643-1658 cm−1) and propargyl fragment vibration bands (3231-3279 cm−1) were observed. 1H NMR spectral analysis of the synthesized N-propargyl tetrahydroquinolines showed four groups of characterized signals. First, signals between 6.88-7.31 ppm indicated the presence of aromatic protons corresponding to the tetrahydroquinoline ring. Also was possible to observe the aliphatic proton signals, around 5.10–1.99 ppm, corresponding to THQ nucleus and the signal for the alkyne proton between 2.13–2.28 ppm. Finally, around 8.11–8.21 ppm, proton signal for formamide group was observed. This set of signals constitutes evidence that the formation of the tetrahydroquinoline compounds took place favorably. 1H and 13C nuclear magnetic resonance (NMR) spectra of compound 6a-6g are included in supplementary material (Fig S1-FigS7).

The presence of a fragment N-propargyl in the new compounds is interesting owing to propargylamines are useful synthetic precursors in the obtaining of different organic substrates, natural products, and drugs as evidenced by the large number of articles published in the literature (Hua and Nizami, 2018; Lauder et al., 2017: Yang et al., 2018). The versatility of propargylamines is due to its unique structure composed of an amine group in β-position to an alkyne moiety. Compounds with a carbon−carbon triple bond have characteristic reactivity and can behave as electrophilic substrates and as an electron source in nucleophilic reactions (Mao et al., 2015). It is worth noting that, as mentioned above, some N-propargyl derivatives have been applied mainly as monoamine oxidase inhibitors (IMAO) and, according to the literature, could promote antioxidant effects by acting as radical scavengers (Dragoni et al., 2006).

All compounds obtained were evaluated as antioxidant agents in presence of the stable radical DPPH (1,1-diphenyl-2-picrylhydrazyl) at a concentration ranging from 10 to 100 μL and compared with ascorbic acid as shown in Table 2. The DPPH scavenging activity varied greatly. There were no clear differences in IC50 values between the compounds synthesized despite the presence of substituents with different chemical properties and was not possible to observe an antioxidant effect compared with standard.

Table 2.

% Decoloration of DPPH solution for synthesized compounds in comparation with ascorbic acid. Values are the average of triplicate experiments.

Concentration (μg/mL)
Compound 100 50 10 IC50
6a 12.63 ± 1.2 5.26 ± 1.5 1.04 ± 0.2 >100
6b 19.74 ± 3.2 10.52 ± 1.5 0.00 ± 0.0 >100
6c 45.53 ± 5.6 29.47 ± 4.1 21.05 ± 5.1 >100
6d 22.37 ± 2.4 16.58 ± 3.3 7.11 ± 2.0 >100
6e 22.63 ± 3.7 18.42 ± 2.5 6.58 ± 2.1 >100
6f 18.16 ± 5.5 7.89 ± 1.3 5.26 ± 1.2 >100
6g 20.00 ± 7.0 9.73 ± 0.8 2.8 ± 1.3 >100
Ascorbic acid - - - 1 ± 0.3

On the other hand, Table 3 showed that compounds 6b, 6c, 6d, and 6g have good activity in scavenging ABTS radical, presenting better IC50 values than those found for ascorbic acid, used as reference. This is consistent with the results reported previously where described compounds having an electron withdrawing group like fluorine, and electron donating groups, like methoxy on the phenyl rings, exhibit good antioxidant activity (Mubeen et al., 2015; Polo et al., 2016).

Table 3.

ABTS radical scavenging activity (%) of the synthesized compounds, measured at 745 nm, compared to standard ascorbic acid. Values are the average of triplicate experiments.

Concentration (μg/mL)
Compound 100 50 10 IC50
6a 90.41 ± 8.7 75.27 ± 6.4 46.27 ± 2.1 12.30 ± 4.2
6b 98.08 ± 5.8 88.49 ± 6.6 79.32 ± 9.3 3.72 ± 0.7
6c 93.54 ± 7.5 91.68 ± 5.9 82.30 ± 5.4 2.12 ± 0.8
6d 94.03 ± 9.2 53.73 ± 5.0 78.46 ± 9.5 3.35 ± 0.5
6e 81.45 ± 6.2 68.88 ± 4.8 36.93 ± 8.6 41.15 ± 6.3
6f 86.31 ± 5.6 70.95 ± 6.6 6.85 ± 2.0 32.09 ± 2.5
6g 92.53 ± 8.7 82.99 ± 8.5 72.82 ± 6.5 2.98 ± 0.7
Ascorbic acid - - - 35 ± 2.7

Computational methods are important tools to predict some compound properties with interesting experimental biological activities, e.g, QikProp is a quick, accurate, and easy to use absorption, distribution, metabolism, and excretion (ADME) prediction program (Schrödinger, 2017). The main parameters are shown in Table 4. Taking into account the Lipinski's rule of five (molecular weight below 500 Da, hydrogen bond donor less than 5, acceptor less than 10, and Log P (octanol/water partition coefficient) for the ligand less than five), the synthesized compounds did not present violations to this rule, being within of permissible range of each descriptor (Lipinski et al., 1997). Likewise, the synthesized THQ series satisfies other parameters involved in the absorption, distribution and membrane penetration as water solubility (Log S) and polar surface area (PSA). Finally, the predicted qualitative oral absorption was calculated. This prediction is made through the analysis of the appropriate values of different descriptors. The analysis showed that the compounds could present good oral absorption. In general, the new N-propargyl tetrahydroquinolines presented permissible values in the different descriptors calculated (Singh et al., 2012).

Table 4.

Computer aided ADME screening of the synthesized compounds N-propargyl tetrahydroquinolines.

Compound M.W. (g/mol) Log P (o/w)a donors HBb acceptors HBc Log Sd PSAe Human Oral Absorptionf
6a 214.266 1.628 1.500 3.500 −1.827 51.657 3
6b 228.293 1.882 1.500 3.500 −2.030 51.857 3
6c 244.293 1.697 1.500 4.250 −1.750 60.103 3
6d 242.320 2.230 1.500 3.500 −2.398 51.878 3
6e 293.162 2.068 1.500 3.500 −2.225 50.692 3
6f 248.711 2.068 1.500 3.500 −2.205 51.858 3
6g 232.257 1.725 1.500 3.500 −1.710 50.726 3
a

log P for octanol/water (−2.0 – −6.5).

b

Estimated number of H-bonds that would be donated by the solute to water molecules in an aqueous solution.

c

Estimated number of H-bonds that would be accepted by solute from water molecules in an aqueous solution.

d

Predicted aqueous solubility, log S, S in mol dm−3 (−6.5 – 0.5).

e

Van der Waals surface areas of polar nitrogen and oxygen atoms.

f

Qualitative human oral absorption predicted: 1, 2 or 3 for low, medium or high.

To understand the biological activity reported, an analysis of chemical reactivity were developed and Quantum Similarity field and Chemical reactivity framework were used. Taking into account the structural features of these molecular sets, which have only a substitute, the molecular quantum similarity indices allowed us to quantify the structural and electronic effects from a local point of view. The highest overlap similarity was observed between 6e and 6b and for 6d and 6f with a value of 0.9998 in both cases (Table 5), with a Euclidean distance of 1.3725 and 0.7756 respectively (Table 6).

Table 5.

Molecular quantum Similarity values using the overlap operator.

6a 6b 6c 6d 6e 6f 6g
6a 1.0000
6b 0.9954 1.0000
6c 0.9897 0.9985 1.0000
6d 0.9895 0.9958 0.9935 1.0000
6e 0.9957 0.9998 0.9958 0.9964 1.0000
6f 0.9913 0.9995 0.9958 0.9998 0.9993 1.0000
6g 0.9915 0.9978 0.9932 0.9952 0.9959 0.9964 1.0000

Table 6.

Molecular Quantum Similarity values using the Euclidean distance for the overlap operator.

6a 6b 6c 6d 6e 6f 6g
6a 0.0000
6b 4.1721 0.0000
6c 7.9565 4.5485 0.0000
6d 7.4087 4.1515 2.2423 0.0000
6e 3.9958 1.3725 4.8028 4.2161 0.0000
6f 4.2546 1.5458 4.2535 0.7756 3.5410 0.0000
6g 5.3227 2.8750 4.6077 5.1883 3.5665 3.0600 0.0000

The most active compound 6c has a high overlap similarity value with the compounds 6b (0.9985), 6e and 6f (0.9985), with euclidean distances of 4.5485, 4.8028 and 4.2535 respectively. Compound 6c also has a high electronic similarity with the compounds 6d (0.9709), 6e (0.9417), 6f (0.9512), 6g (0.9589) (See Table S1, supporting information) with euclidean distances of 0.9481, 1.3324, 1.2288, 1.1379, respectively (See Table S2, supporting information). These compounds 6e, 6f, and 6g have strong electron withdrawing groups such as –Br, -Cl and –F compared with compound 6c which has a methoxy group. In general, the electronic similarity values are higher than the Overlap similarity values. For this reason, chemical reactivity descriptors are reported in Table 7.

Table 7.

Global reactivity descriptors for the compounds.

Compound C. Potential (μ, eV) C. Hardness (ɳ,eV) Softness (S, eV)−1 Electrophilicity (ω, eV)
6a -3.5233 7.8842 0.1268 0.7873
6b -3.3652 7.5548 0.2838 0.7494
6c -3.2856 7.2253 0.3043 0.7470
6d -3.3456 7.6528 0.2989 0.7313
6e -3.6483 7.3599 0.2741 0.9042
6f -3.6551 7.3985 0.2735 0.9028
6g -3.6085 7.3956 0.2771 0.8803

The higher chemical potential is shown for the compound 6f (μ = -3.6551 eV), hardness (ɳ = 7.3985 eV), softness (S = 0.2735 eV−1) and electrophilicity (ω = 0.9028 eV). The most reactive compound 6c has chemical potential (μ = -3.2856), hardness (ɳ = 7.2253 eV), softness (S = 0.3043 eV−1) and electrophilicity (ω = 0.7470 eV). These reactivity parameters of new compounds can be related to the properties as free radical scavengers.

Fig. 2 shows the Fukui Functionfk|HOMO|2 andfk+|LUMO|2figures for the selected compound 6c (most active compound, 3a and 6a (reference compound to series 3 and 6 respectively).

Fig. 2.

Fig. 2

Fukui Funtionsfk|HOMO|2andfk+|LUMO|2, for the compound selected 6c (most active compound), 6a and 3a (reference compounds to series 6 and precursors 3 respectively).

Compounds 3a and 6a have the same reactivity maps in both figures. These reactivity maps can be related to the retrodonor process on the non-covalent interaction for these compounds (Wenqin et al., 2015; Jørgensen, 2000). Unlike the reference compounds, the most active compound 6c has different maps for the Fukui Functionsfk|HOMO|2andfk+|LUMO|2 respectively. Therefore, the compound 6c has zones good defined for electrophilic and nucleophilic attacks that can influence their activity. Finally, the local electrophilicity and nucleophilicity dissimilarity using DFT Based Reactivity Descriptors, to relate the chemical reactivity with the quantum similarity, are shown in Table 8. The compound 6c has the higher local reactivity similarity (electrophilicity dissimilarity: 0.041), and the compound 6d has the higher nucleophilicity dissimilarity: 5.52 × 10−3 with respect to the reference compound 6a. Theses dissimilarities can be related to the zone of reactivity (the Fukui function maps, see Fig. 2) in this series of compounds.

Table 8.

Local electrophilicity and nucleophilicity dissimilarity.

Reference Compound (6a) vs Electrophilicity dissimilarity Nucleophilicity dissimilarity
6b 7.51 × 10−3 4.09 × 10−3
6c 0.041 4.91 × 10−3
6d 9.89 × 10−3 5.52 × 10−3
6e 3.35 × 10−3 1.19 × 10−3
6f 5.22 × 10−3 4.28 × 10−4
6g 4.29 × 10−3 2.79 × 10−3

3. Experimental

3.1. Chemistry

All reagents were purchased from either Merck (Darmstadt, Germany) or Sigma and Aldrich Chemical Co (St. Louis, MO, USA) and used without further purification. All products were characterized by spectral data (IR, MS, 1H-NMR, 13C-NMR). NMR spectra (1H and 13C) were measured on a Bruker Ultrashield-400 spectrometer (Rheinstetten, Germany), using CDCl3 as solvent and reference. J values are reported in Hz; chemical shifts are reported in ppm (δ) relative to the solvent peak (residual CHCl3 in CDCl3 at 7.26 ppm for protons and 77 ppm for carbon atoms). Signals were designated as follows: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; td, triplet of doublets; q, quartet; m, multiplet, and br., broad. IR spectra (KBr pellets, 500–4000 cm−1) were recorded on a NEXUS 670 FT-IR spectrophotometer (Thermo Nicolet, Madison, WI, USA). GC-MS analyses were performed on a model Trace 1300 GC-MS instrument (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a Rtx-5MS on-column auto-injector and a fused silica capillary column (DB-5, 30 m ˆ 0.25 mm ID, 0.25 μm film thickness). MS were recorded in electron ionization (EI) mode, with the energy of 70 eV. The ion source temperature was 200 °C; 4.00 min solvent cut time. Melting points (uncorrected) were measured on an Electrothermal IA9100 melting point apparatus (Stone, Staffs, UK). The reaction progress was monitored using thin layer chromatography on PF254 TLC aluminum sheets from Merck. Column chromatography was performed using Silica gel (60–120 mesh) and Solvents employed were of analytical grade.

3.2. General procedure for the synthesis of N-propargyl-1,2,3,4-THQs

THQ derivatives were efficiently synthesized according to methodology reported previously (Rodriguez et al., 2016), the protocol outlined in Fig. 1. This protocol can be divided into two steps:

3.2.1. Step 1: preparation of N-propargylamine

In a round-bottomed flask, a 5-mL solution in anhydrous DMF of the corresponding anilines 1 (1.8 mmol), potassium iodide (0.1 mmol) and anhydrous sodium carbonate (2 mmol) was prepared and stirred constantly at 0 °C. A solution of propargyl bromide 2 (1.0 mmol) in anhydrous DMF was added dropwise and the mixture was kept at 0 °C for 20 minutes. The reaction was allowed to stir at room temperature for 3–4 h, indicated on TLC. The reaction mixture was diluted with water and extracted with ethyl acetate (3 × 20 mL), the organic phase was separated and dried (Na2SO4), the solvent removed under vacuum and the resulting product was purified by column chromatography on silica gel, (petroleum ether: ethyl acetate) to obtain the pure N-propargyl anilines 3a-g.

3.2.2. Step 2: preparation of N-propargyl THQs

All the reactions were performed at room temperature. In a round bottom flask, a 5 mL solution in CH3CN of preformed N-propargylaniline 3a-g (1.0 mmol) and formaldehyde (37% in methanol) 4 (1.1 mmol) was prepared and stirred for 10 minutes. 5 mL solution of InCl3 (20% mol) in CH3CN was then added. After 20 minutes a solution of N-vinylformamide 5 (1.1 mmol) in CH3CN was incorporated to the reaction mixture and was vigorously stirred. The resulting mixture was stirred for 3–4 h. After the workup, the final product was purified by column chromatography, eluted with the appropriate mixture of petroleum ether and ethyl acetate to afford pure THQs 6a-g.

3.2.3. N-(1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6a)

Coffee solid; m.p. 118–120 °C; Yield 51%; IR: 3279, 3038, 2958, 2922, 2847, 1658, 1492, 751; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.20 (1H, s), 7.22–7.31 (2H, m), 6.82–6.88 (2H, m), 5.21–5.28 (1H, m), 4.19–4.26 (1H, dd, J = 18.2, 1.7 Hz), 4.00–4.07 (1H, dd, J = 18.2, 1.1 Hz), 3.32–3.39 (2H, m), 2.25–2.28 (1H, s), 2.15–2.24 (2H, m). 13C NMR (100 MHz, CDCl3) δ (ppm):160.09, 144.57, 129.60, 129.17, 122.23, 118.11, 112.81, 79.01, 72.09, 45.24, 44.76, 40.72, 28.48; GC-MS m/z (rel. int. %): 213.80 (24), 174.88 (10), 167.78 (100), 129.88 (20). Anal. Calc. for C13H14N2O: 214.11 uma.

3.2.4. N-(6-methyl-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6b)

Orange solid; m.p. 134–136 °C; Yield 95%; IR: 3278, 2951, 2923, 2854, 1655, 1506, 1380, 1328, 1230, 803; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.18 (1H, s), 6.97–7.05 (2H, m), 6.70 (1H, d, J = 8.3 Hz), 5.16 (1H, d, J = 6.1 Hz), 4.09–4.16 (1H, d, J = 18.1 Hz), 3.88–3.95 (1H, d, J = 18.1 Hz), 3.21–3.26 (2H, m), 2.22–2.24 (3H, s), 2.15 (1H, br), 1.99–2.14 (2H, m). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.04, 142.37, 130.11, 129.74, 127.53, 122.40, 113.11, 79.08, 72.08, 45.34, 44.66, 40.86, 28.75, 20.23; GC-MS m/z (rel. int. %): 227.71 (38), 188.92 (10), 181.88 (100), 166.87 (12), 143.97 (24). Anal. Calc. for C14H16N2O: 228.13 uma.

3.2.5. N-(6-methoxy-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6c)

Coffee solid; m.p. 110–112 °C; Yield 66%; IR: 3262, 3231, 2953, 2917, 2845, 1653, 1501, 1460, 1374, 1048, 737; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.18 (1H, s), 6.80 (1H, dd, J = 8.9, 3.0 Hz), 6.71–6.76 (2H, m), 5.17 (1H, dd, J = 12.9, 5.1 Hz), 4.10 (1H, dd, J = 18.1, 2.2 Hz), 3.90 (1H, dd, J = 18.1, 2.3 Hz), 3.73 (3H, s), 3.18–3.22 (2H, m), 2.13–2.15 (1H, br), 2.04–2.23 (2H, m). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.05, 152.33, 138.91, 123.74, 115.25, 114.57, 114.51, 79.11, 72.20, 55.71, 45.55, 44.85, 41.22, 28.94; GC-MS m/z (rel. int. %): 243.76 (80), 204.89 (12), 197.97 (100), 159.64 (28), 144.80 (16). Anal. Calc. for C14H16N2O2: 244.12 uma.

3.2.6. N-(6-ethyl-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6d)

Beige solid; m.p. 116–118 °C; Yield 31%; IR: 3273, 3231, 2951, 2923, 2849, 1648, 1506, 1376, 1331, 804; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.11 (1H, s), 7.03 (1H, d, J = 8.1 Hz), 6.97 (1H, d, J = 14.5 Hz), 6.71 (1H, d, J = 8.4 Hz), 5.10–5.17 (1H, m), 4.11 (1H, d, J = 18.1 Hz), 3.91 (1H, d, J = 18.1 Hz), 3,18–33.26 (2H, m), 2.52 (2H, q, J = 7.5 Hz), 2.15 (1H, t, J = 6.6 Hz), 2.03–2.13 (2H, m), 1.18 (3H, t, J = 7.6 Hz). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.15, 142.56, 133.99, 128.94, 128.50, 122.32, 113.02, 79.19, 72.11, 45.32, 44.70, 40.83, 28.74, 27.74, 15.74; GC-MS m/z (rel. int. %): 242.03 (34), 195.93 (100), 181.81 (12), 157.78 (22). Anal. Calc. for C15H18N2O: 242.14 uma.

3.2.7. N-(6-bromo-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6e)

White solid; m.p. 164–166 °C; Yield 52%; IR: 3239, 3044, 2956, 2920, 2851, 1645, 1490, 1241, 891; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.19 (1H, s), 7.21–7.25 (2H, m), 6.62 (1H, d, J = 9.1 Hz), 5.15 (1H, dd, J = 11.4, 5.1 Hz), 4.07 (1H, d, J = 18.3 Hz), 3.91 (1H, d, J= 18.2 Hz), 3.26 (2H, t, J= 5.6 Hz), 2.13–2.17 (1H, br), 1.99–2.13 (2H, m). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.85, 143.81, 131.33, 131.03, 125.38, 114.35, 109.09, 78.92, 72.90, 45.90, 43.78, 40.71, 28.59; GC-MS m/z (rel. int. %): 291.52 (40), 247.98 (100), 209.76 (28), 166.82 (62). Anal. Calc. for C13H13BrN2O: 292.02 uma.

3.2.8. N-(6-chloro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6f)

Beige solid; m.p. 158–160 °C; Yield 23%; IR: 3231, 2949, 2914, 2842, 1643, 1494, 1387, 1331, 1238; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.21 (1H, s); 7.11–7.16 (2H, m), 6.69 (1H, d, J = 9.0 Hz), 5.14–5.20 (1H, m), 4.10 (1H, d, J = 18.2 Hz), 3.94 (1H, d, J = 18.3 Hz), 3.20–3.25 (2H, m), 2.15–2.18 (1H, br), 2.02–2.15 (2H, m). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.09, 143.15, 129.19, 128.95, 123.86, 122.84, 114.16, 78.50, 72.37, 45.43, 44.48, 40.86, 28.43; GC-MS m/z (rel. int. %): 247.78 (44), 208.85 (15), 201.64 (100), 166.90 (40). Anal. Calc. for C13H13ClN2O: 248.07 uma.

3.2.9. N-(6-fluoro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide (6g)

Beige solid; m.p. 144–146 °C; Yield 71%; IR: 3273, 3257, 2954, 2915, 1650, 1503, 801; 1H NMR (400 MHz, CDCl3) δ (ppm): 8.19 (1H, s), 6.88–6.93 (2H, m), 6.67–6.73 (1H, m), 5.17 (1H, dd, J = 13.2, 5.4 Hz), 4.08 (1H, dd, J = 18.2, 2.2 Hz), 3.93 (1H, dd, J = 18.2, 2.2 Hz), 3.21–3.26 (2H, m), 2.15–2.17 (1H, br), 1.99–2.20 (2H. m). 13C NMR (100 MHz, CDCl3) δ (ppm): 160.14, 141.04, 123.94, 115.78, 115.56, 114.13, 114.06, 78.74, 72.34, 45.67, 44.60, 41.16, 28.72; GC-MS m/z (rel. int. %): 231.80 (28), 192.85 (10), 185.78 (100), 147.74 (30). Anal. Calc. for C13H13FN2O: 232.10 uma.

3.3. Measurement of DPPH radical scavenging activity

DPPH is a stable free radical that can accept an electron or hydrogen radical to become a stable molecule. The antioxidant activity can be observed by a change of coloration deep violet to yellow in the mixture of compounds with a methanolic solution of DPPH. The hydrogen atom or electron donation ability of the compounds was measured from the bleaching of the purple colored methanol solution of DPPH (Kedare and Singh, 2011).

The free radical scavenging effect of the compounds was assessed by the discoloration of a methanolic solution of DPPH as previously reported (Polo et al., 2016). Tetrahydroquinolines 6a-g was assayed at 100, 50 and 10 μg/mL. The scavenging of free radicals by THQs was evaluated spectrophotometrically at 517 nm against the absorbance of the DPPH radical. The percentage of discoloration was calculated as follows:

% scavenging DPPH free radical = 100 × (1-AE/AD)

Where AE, is the absorbance of the solution after adding the extract and AD is the absorbance of the blank DPPH solution. Ascorbic acid was used as reference compounds, with IC50 value of 1 μg/mL.

3.4. Measurement of ABTS radical scavenging activity

The ABTS (2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging assay is a rapid and efficient method, based on the ability of the hydrogen donating antioxidants to scavenge the long-life radical cation ABTS•+. In this method, the preformed radical monocation of ABTS is generated by the oxidation of ABTS with potassium persulfate and is reduced in the presence of such hydrogen donating antioxidants (Karadag et al., 2009).

ABTS assay was performed according to the protocol (Polo et al., 2016; Re et al., 1999). The ABTS radical cation (ABTS•+) was produced by reaction of 7 mM stock solution of ABTS with 2.45 mM potassium persulfate and allowing the mixture to stand in dark at room temperature for 12 h before use. The ABTS•+ solution was diluted with methanol to give an absorbance of 0.7 ± 0.01 at 745 nm. Compounds (1 mL) were allowed to react with 2 ml of the ABTS•+ solution and the absorbance was measured at 745 nm after 1 min. Data for each assay was recorded in triplicate. Ascorbic acid was used as positive controls with IC50 value of 35 μg/mL. The scavenging activity was estimated based on the percentage of ABTS radicals scavenged by the following formula:

% scavenging = [(A0 − As)/A0] × 100

Where A0 is the absorption of control, AS is the absorption of a tested compound solution.

3.5. In silico prediction of pharmacokinetic properties

Pharmacokinetic properties of THQ compounds were calculated an in silico way through ADME descriptors using QikProp (Caporuscio et al., 2011). Based on the Lipinski's rule of 5, some of the descriptors predicted were molecular weight, Van der Waals, surface areas of polar nitrogen and oxygen atoms, H bond acceptors, H bond donors, Log P (octanol/water) and aqueous solubility (Lipinski et al., 1997), proposing a first analysis of the newly synthesized compounds as drug-likeness.

3.6. Computational methods

The theoretical study was realized based on Molecular Quantum Similarity Measure (MQSM), density functions, analyzing a series of reactive descriptors as chemical hardness (η), chemical potential (μ), electrophilicity index (ω), softness(s), and Fukui functions. All the structures included in this study were optimized at B3LYP/6-31G(d) level of theory by using the Gaussian 09 package (Frisch et al., 2016). Detail and basis of the methods used are included in the supplementary material.

4. Conclusion

In summary, the synthesis of a new series of substituted N-propargylTHQs derivatives has been developed in mild conditions and simple procedure through the Domino Mannich/Friedel - Crafts reactions using InCl3 as catalyst. The antioxidant activity is dependent on the concentration of the compounds, likewise, the compound 6c and 6g (with methoxy and fluorine group on the aromatic ring respectively) presented the most favorable antioxidant activity values. Physicochemical descriptors, calculated theoretically, indicated that the new compounds have a low toxicity risk. Structurally the N-propargyl THQs are attractive for the production of a second generation of compounds due to the reactivity of the propargyl fragment. In this study, we obtained compounds with higher antioxidant capacity than the reference compound. From the theoretical calculations (MQSM, Global reactivity descriptors, and Fukui Functions), we can establish similarity and discriminate different reactive sites in the new molecules where the oxidative process occurs. These sites can be used for the design of new compounds with interesting biological activity.

Declarations

Author contribution statement

Y Rodríguez: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

A Romero: Conceived and designed the experiments; Wrote the paper.

M Gutiérrez: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

M Norambuena: Performed the experiments.

A Morales: Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Funding statement

This work was supported by the Institute of Chemistry of Natural Resources, University of Talca, Chile and PIEI QUIMBIO project, UTalca.

Competing interest statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Appendix A. Supplementary data

The following is the supplementary data related to this article:

Supporting Information heliyon 2207_V2
mmc1.docx (731.3KB, docx)

References

  1. Aruoma O.I. Free radicals, oxidative stress, and antioxidants in human health and disease. J. Am. Oil Chem. Soc. 1998;75(2):199–212. doi: 10.1007/s11746-998-0032-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abonia R., Castillo J., Insuasty B., Quiroga J., Nogueras M., Cobo J. Efficient catalyst-free four-component synthesis of novel γ-aminoethers mediated by a Mannich type reaction. ACS Comb. Sci. 2013;15(1):2–9. doi: 10.1021/co300105t. [DOI] [PubMed] [Google Scholar]
  3. Acelas M., Bohórquez A.R.R., Kouznetsov V.V. Highly diastereoselective synthesis of new trans-fused octahydro-acridines via intramolecular cationic imino diels–alder reaction of N-protected anilines and citronellal or citronella essential oil. Synthesis. 2017;49(10):2153–2162. [Google Scholar]
  4. Baranyi M., Porceddu P.F., Goloncser F., Kulcsar S., Otrokocsi L., Kittel A., Pinna A., Frau L., Huleatt P.B., Khoo M.L., Chai C.L., Dunkel P., Matyus P., Morelli M., Sperlagh B. Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease. Mol. Neurodegener. 2016;11(6):015–0067. doi: 10.1186/s13024-015-0067-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bolea I., Gella A., Unzeta M. Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors. J. Neural Transm. 2013;120(6):893–902. doi: 10.1007/s00702-012-0948-y. [DOI] [PubMed] [Google Scholar]
  6. Bulut N., Kocyigit U.M., Gecibesler I.H., Dastan T., Karci H., Taslimi P., Sevgi D., Ilhami G., Cetin A. Synthesis of some novel pyridine compounds containing bis-1, 2, 4-triazole/thiosemicarbazide moiety and investigation of their antioxidant properties, carbonic anhydrase, and acetylcholinesterase enzymes inhibition profiles. J. Biochem. Mol. Toxicol. 2018;32(1) doi: 10.1002/jbt.22006. [DOI] [PubMed] [Google Scholar]
  7. Caporuscio F., Rastelli G., Imbriano C., Del Rio A. Structure-based design of potent aromatase inhibitors by high-throughput docking. J. Med. Chem. 2011;54(12):4006–4017. doi: 10.1021/jm2000689. [DOI] [PubMed] [Google Scholar]
  8. Dragoni S., Porcari V., Travagli M., Castagnolo D., Valoti M. Antioxidant properties of propargylamine derivatives: assessment of their ability to scavenge peroxynitrite. J. Pharm. Pharmacol. 2006;58(4):561–565. doi: 10.1211/jpp.58.4.0016. [DOI] [PubMed] [Google Scholar]
  9. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Petersson G.A., Nakatsuji H., Li X., Caricato M., Marenich A., Bloino J., Janesko B.G., Gomperts R., Mennucci B., Hratchian H.P., Ortiz J.V., Izmaylov A.F., Sonnenberg J.L., Williams-Young D., Ding F., Lipparini F., Egidi F., Goings J., Peng B., Petrone A., Henderson T., Ranasinghe D., Zakrzewski V.G., Gao J., Rega N., Zheng G., Liang W., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., Throssell K., Montgomery J.A., Jr., Peralta J.E., Ogliaro F., Bearpark M., Heyd J.J., Brothers E., Kudin K.N., Staroverov V.N., Keith T., Kobayashi R., Normand J., Raghavachari K., Rendell A., Burant J.C., Iyengar S.S., Tomasi J., Cossi M., Millam J.M., Klene M., Adamo C., Cammi R., Ochterski J.W., Martin R.L., Morokuma K., Farkas O., Foresman J.B., Fox D.J. 2016. Gaussian 09, Revision A.02. M., Wallingford, CT. [Google Scholar]
  10. Hua R., Nizami T.A. Synthesis of heterocycles by using propargyl compounds as versatile synthons. Mini-Reviews Org. Chem. 2018;15(3):198–207. [Google Scholar]
  11. Jørgensen K.A. Catalytic asymmetric hetero-diels–alder reactions of carbonyl compounds and imines. Angew. Chem. Int. Ed. 2000;39(20):3558–3588. doi: 10.1002/1521-3773(20001016)39:20<3558::aid-anie3558>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  12. Karadag A., Ozcelik B., Saner S. Review of methods to determine antioxidant capacities. Food. Anal. Method. 2009;2(1):41–60. [Google Scholar]
  13. Katritzky A.R., Rachwal S., Rachwal B. Recent progress in the synthesis of 1,2,3,4,-tetrahydroquinolines. Tetrahedron. 1996;52(48):15031–15070. [Google Scholar]
  14. Kedare S.B., Singh R.P. Genesis and development of DPPH method of antioxidant assay. J. Food. Sci. Tech. Mys. 2011;48(4):412–422. doi: 10.1007/s13197-011-0251-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kouznetsov V.V., Gómez C.M.M., Parada L.K.L., Bermudez J.H., Méndez L.Y.V., Acevedo A.M. Efficient synthesis and free-radical scavenging capacity of new 2,4-substituted tetrahydroquinolines prepared via BiCl3-catalyzed three-component Povarov reaction, using N-vinylamides. Mol. Divers. 2011;15(4):1007. doi: 10.1007/s11030-011-9330-5. [DOI] [PubMed] [Google Scholar]
  16. Lauder K., Toscani A., Scalacci N., Castagnolo D. Synthesis and reactivity of propargylamines in organic chemistry. Chem. Rev. 2017;117(24):14091–14200. doi: 10.1021/acs.chemrev.7b00343. [DOI] [PubMed] [Google Scholar]
  17. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23(1-3):3–25. doi: 10.1016/s0169-409x(00)00129-0. [DOI] [PubMed] [Google Scholar]
  18. Mao F., Li J., Wei H., Huang L., Li X. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease. J. Enzym. Inhib. Med. Chem. 2015;30(6):995–1001. doi: 10.3109/14756366.2014.1003212. [DOI] [PubMed] [Google Scholar]
  19. Martelli G., Giacomini D. Antibacterial and antioxidant activities for natural and synthetic dual-active compounds. Eur. J. Med. Chem. 2018;158:91–105. doi: 10.1016/j.ejmech.2018.09.009. [DOI] [PubMed] [Google Scholar]
  20. Mubeen M., Kini S.G., Pai K.S.R. Design, synthesis, antioxidant and anticancer activity of novel pyrazole derivatives. Der. Pharm. Chem. 2015;7(2):215–223. [Google Scholar]
  21. Nammalwar B., Bunce A.R. Recent syntheses of 1,2,3,4-tetrahydroquinolines, 2,3-dihydro-4(1H)-quinolinones and 4(1H)-Quinolinones using domino reactions. Molecules. 2014;19(1) doi: 10.3390/molecules19010204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Polo E., Trilleras J., Ramos J., Galdámez A., Quiroga J., Gutierrez M. Efficient MW-assisted synthesis, spectroscopic characterization, X-ray and antioxidant properties of indazole derivatives. Molecules. 2016;21(7) doi: 10.3390/molecules21070903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999;26(9-10):1231–1237. doi: 10.1016/s0891-5849(98)00315-3. [DOI] [PubMed] [Google Scholar]
  24. Rodriguez Y.A., Gutierrez M., Ramirez D., Alzate-Morales J., Bernal C.C., Guiza F.M., Romero Bohorquez A.R. Novel N-allyl/propargyl tetrahydroquinolines: synthesis via three-component cationic imino diels-alder reaction, binding prediction, and evaluation as cholinesterase inhibitors. Chem. Biol. Drug Des. 2016;88(4):498–510. doi: 10.1111/cbdd.12773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Romero Bohórquez A., Romero-Daza J., Acelas M. Versatile and mild HCl-catalyzed cationic imino Diels-Alder reaction for the synthesis of new tetrahydroquinoline derivatives. Synth. Commun. 2016;46(4) [Google Scholar]
  26. Singh K.D., Kirubakaran P., Nagarajan S., Sakkiah S., Muthusamy K., Velmurgan D., Jeyakanthan J. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. J. Mol. Model. 2012;18(1):39–51. doi: 10.1007/s00894-011-1018-3. [DOI] [PubMed] [Google Scholar]
  27. Sridharan V., Suryavanshi P.A., Menéndez J.C. Advances in the chemistry of tetrahydroquinolines. Chem. Rev. 2011;111(11):7157–7259. doi: 10.1021/cr100307m. [DOI] [PubMed] [Google Scholar]
  28. Schrödinger . LigPrep, S., LLC; New York, NY: 2017. Release 2017-3. [Google Scholar]
  29. Wenqin X., Wei W., Xiang W. Gold-catalyzed cyclization leads to a bridged tetracyclic indolenine that represses beta-lactam resistance. Angew. Chem., Int. Ed. Engl. 2015;54(33):9546–9549. doi: 10.1002/anie.201503736. [DOI] [PubMed] [Google Scholar]
  30. Yang Y., Hu Z.L., Li R.H., Chen Y.H., Zhan Z.P. Pyrazole synthesis via a cascade Sonogashira coupling/cyclization of N-propargyl sulfonylhydrazones. Org. Biomol. Chem. 2018;16(2):197–201. doi: 10.1039/c7ob02576a. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information heliyon 2207_V2
mmc1.docx (731.3KB, docx)

Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES